Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Cholesterol Lowering Biologic Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Cholesterol Lowering Biologic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Cholesterol Lowering Biologic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Regeneron Pharmaceuticals
Amgen
Alnylam Pharmaceuticals
By Type:
For Oral Administration
Injectable Drugs
By End-User:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholesterol Lowering Biologic Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of For Oral Administration from 2016 to 2027
-
1.3.2 China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Injectable Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
1.4.4 China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Online Sales from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Cholesterol Lowering Biologic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cholesterol Lowering Biologic Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of For Oral Administration
-
3.4.2 Market Size and Growth Rate of Injectable Drugs
4 Segmentation of Cholesterol Lowering Biologic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cholesterol Lowering Biologic Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Drug Stores
-
4.4.4 Market Size and Growth Rate of Cholesterol Lowering Biologic Drugs in Online Sales
5 Market Analysis by Regions
-
5.1 China Cholesterol Lowering Biologic Drugs Production Analysis by Regions
-
5.2 China Cholesterol Lowering Biologic Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
6.1 North China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
6.2 North China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
7 Central China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
7.1 Central China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
7.2 Central China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
8 South China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
8.1 South China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
8.2 South China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
9 East China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
9.1 East China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
9.2 East China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
10 Northeast China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
10.1 Northeast China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
11 Southwest China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
11.1 Southwest China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
12 Northwest China Cholesterol Lowering Biologic Drugs Landscape Analysis
-
12.1 Northwest China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Cholesterol Lowering Biologic Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Regeneron Pharmaceuticals
-
13.1.1 Regeneron Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Amgen
-
13.2.1 Amgen Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Alnylam Pharmaceuticals
-
13.3.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of For Oral Administration from 2016 to 2027
-
Figure China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Injectable Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Drug Stores from 2016 to 2027
-
Figure China Cholesterol Lowering Biologic Drugs Market Size and Growth Rate of Online Sales from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Cholesterol Lowering Biologic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Cholesterol Lowering Biologic Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cholesterol Lowering Biologic Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Cholesterol Lowering Biologic Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of For Oral Administration
-
Figure Market Size and Growth Rate of Injectable Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Cholesterol Lowering Biologic Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Cholesterol Lowering Biologic Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Drug Stores
-
Figure Market Size and Growth Rate of Online Sales
-
Table China Cholesterol Lowering Biologic Drugs Production by Regions
-
Table China Cholesterol Lowering Biologic Drugs Production Share by Regions
-
Figure China Cholesterol Lowering Biologic Drugs Production Share by Regions in 2016
-
Figure China Cholesterol Lowering Biologic Drugs Production Share by Regions in 2021
-
Figure China Cholesterol Lowering Biologic Drugs Production Share by Regions in 2027
-
Table China Cholesterol Lowering Biologic Drugs Consumption by Regions
-
Table China Cholesterol Lowering Biologic Drugs Consumption Share by Regions
-
Figure China Cholesterol Lowering Biologic Drugs Consumption Share by Regions in 2016
-
Figure China Cholesterol Lowering Biologic Drugs Consumption Share by Regions in 2021
-
Figure China Cholesterol Lowering Biologic Drugs Consumption Share by Regions in 2027
-
Table North China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table North China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table North China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure North China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Central China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Central China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table Central China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Central China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table South China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table South China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table South China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure South China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table East China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table East China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table East China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure East China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table Northeast China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table Southwest China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Cholesterol Lowering Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2016
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2021
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by Types in 2027
-
Table Northwest China Cholesterol Lowering Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Cholesterol Lowering Biologic Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Regeneron Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals
-
Table Product and Service Introduction of Regeneron Pharmaceuticals
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
